XML 168 R56.htm IDEA: XBRL DOCUMENT v3.25.1
EQUITY METHOD INVESTMENTS (Details Narrative)
3 Months Ended 12 Months Ended
Mar. 31, 2025
EUR (€)
Dec. 31, 2024
USD ($)
Dec. 31, 2024
EUR (€)
Dec. 31, 2024
CAD ($)
Dec. 31, 2023
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2024
Gain on extinguishment of debt         $ (1,910,967)    
Cosmo Farmacy LP [Member]              
Initial share capital | € € 150,000   € 150,000        
Initial share capital increased | € 500,000   500,000        
Pharmacy license value | € € 350,000   € 350,000        
Maturity period of license 30 years 30 years 30 years 30 years      
Ownership equity   70.00%         70.00%
Cash contributed to limited partner | € € 150,000   € 150,000        
Equity ownership remaining   30.00%         30.00%
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member]              
Upfront cash received       $ 2,000,000      
Fair value of settlement account   $ 1,554,590          
Gain on extinguishment of debt   $ 1,554,590          
Agreement term   five years five years five years      
Cash received upon gross sales       $ 2,750,000      
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales One [Member]              
Cash received upon gross sales       2,750,000      
Gross sales       13,000,000      
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales [Member]              
Cash received upon gross sales       2,750,000      
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales [Member]              
Gross sales       $ 6,500,000      
Share Exchange Agreement [Member] | ICC [Member]              
Investement   $ 0     $ 160,470 $ 0